Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ROSS GROUP PLC A holding company in liquidation, formerly providing supply chain management & technology solutions.	United Kingdom	RGP
ROXX, Inc. HR tech platform connecting non-desk job seekers with full-time roles using AI and vetting tools.	Japan	241A
SAFTEC CO.,LTD. Rents and sells safety equipment for construction, from basic supplies to AI/IoT solutions.	Japan	7464
Saniona Develops ion channel medicines for rare neurological diseases and epilepsy.	Denmark	SANION
Santech Holdings Ltd A technology company developing innovative consumer and enterprise technology businesses.	United States of America	STEC
SBI Leasing Services Co.,Ltd. Structures Japanese Operating Leases for aircraft & ships for corporate investors.	Japan	5834
Schrodinger, Inc. A physics-based computational platform for accelerated drug and materials discovery.	United States of America	SDGR
Sensorion Developing gene therapies and small molecules to restore, treat, and prevent hearing loss.	France	ALSEN
SERENDIP HOLDINGS Co.,Ltd. Consulting & investment firm aiding manufacturing SMEs with M&A, succession, and revitalization.	Japan	7318
SEYFERT LTD. Provides recruitment, staffing, and education services for the beauty salon industry.	Japan	9213